Seronegative occult hepatitis C infection among hemodialysis patients: A prevalence study

Shahab Mahmoudvand1,2, Somayeh Shokri2, Azarakhsh Azaran1,2

  • 1Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Insights

Occult hepatitis C virus (HCV) infection (OCI) affects 6.3% of hemodialysis patients, detectable in PBMCs despite negative antibodies. Early detection of OCI in hemodialysis patients is crucial for managing complications.

Area of Science:

  • Virology
  • Infectious Diseases
  • Nephrology

Background:

  • Hepatitis C virus (HCV) infection poses risks to hemodialysis (HD) patients.
  • Occult HCV infection (OCI), lacking detectable antibodies, presents diagnostic challenges.

Purpose of the Study:

  • To determine the prevalence of OCI in HD patients.
  • To evaluate diagnostic methods for OCI in this population.

Main Methods:

  • Blood samples from 79 HD patients were analyzed.
  • Sera tested for anti-HCV antibodies.
  • HCV RNA detection in sera and peripheral blood mononuclear cells (PBMCs) using nested RT-PCR.

Main Results:

  • Anti-HCV antibodies detected in 5.1% of patients.
  • HCV RNA found in PBMCs of 6.3% of patients, indicating OCI.
  • HCV genotype 3a was identified in all OCI cases.
  • No significant gender-based difference in OCI frequency.

Conclusions:

  • A 6.3% prevalence of OCI was found in HD patients.
  • Sensitive methods detecting HCV RNA in PBMCs are essential for diagnosing OCI in HD patients.
  • Implementing sensitive diagnostics for OCI is recommended for all HD patients due to potential complications.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
921
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
420
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
253
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
554
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
448
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.9K